[
 {
  "document": {
   "authors": "Abish K",
   "contact_info": "abish@causalitybiomodels.com",
   "copyright": "Copyright \u00a9 2020 Fraunhofer Institute SCAI, All rights reserved",
   "description": "COVID Knowledge Curation project",
   "licences": "Private Ownership to Fraunhofer Institute SCAI",
   "name": "Liu_et.al_2020.bel",
   "version": "2.0.0"
  }
 },
 {
  "definitions": [
   {
    "namespace": {
     "keyword": "CHEBI",
     "type": "URL",
     "value": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/chebi/chebi-20190708.belns",
     "value_list": []
    }
   },
   {
    "namespace": {
     "keyword": "COVID",
     "type": "URL",
     "value": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/ncbi-covid19/ncbi-covid19-20200326.belns",
     "value_list": []
    }
   },
   {
    "namespace": {
     "keyword": "DO",
     "type": "URL",
     "value": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/disease-ontology/disease-ontology-20200407.belns",
     "value_list": []
    }
   },
   {
    "namespace": {
     "keyword": "PUBCHEM",
     "type": "PATTERN",
     "value": "^\\d+$",
     "value_list": []
    }
   },
   {
    "annotation": {
     "keyword": "Species",
     "type": "URL",
     "value": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/species-taxonomy-id/species-taxonomy-id-20170511.belanno",
     "value_list": []
    }
   },
   {
    "annotation": {
     "keyword": "BioAssay",
     "type": "PATTERN",
     "value": ".*",
     "value_list": []
    }
   },
   {
    "annotation": {
     "keyword": "Custom_Disease",
     "type": "LIST",
     "value": null,
     "value_list": [
      "COVID-19"
     ]
    }
   },
   {
    "annotation": {
     "keyword": "PublicationType",
     "type": "LIST",
     "value": null,
     "value_list": [
      "Research"
     ]
    }
   },
   {
    "annotation": {
     "keyword": "PublicationStatus",
     "type": "LIST",
     "value": null,
     "value_list": [
      "Preprint"
     ]
    }
   },
   {
    "annotation": {
     "keyword": "Section",
     "type": "LIST",
     "value": null,
     "value_list": [
      "Results"
     ]
    }
   }
  ]
 },
 {
  "statements_and_sets": [
   {
    "sets": [
     {
      "citation": {
       "type": "DOI",
       "title": "",
       "ref": "10.26434/chemrxiv.11938173.v5",
       "pub_date": "",
       "author_list": "",
       "comment": ""
      }
     },
     {
      "set": {
       "PublicationType": [
        "Research"
       ]
      }
     },
     {
      "set": {
       "PublicationStatus": [
        "Preprint"
       ]
      }
     },
     {
      "set": {
       "Section": [
        "Results"
       ]
      }
     },
     {
      "evidence": "It means that binding E2 glycoprotein to the porphyrin is the most stable, the binding of nucleocapsid phosphoprotein to the porphyrin is unstable, and binding envelope protein to the porphyrin is the most unstable."
     },
     {
      "set": {
       "Species": [
        "9606"
       ]
      }
     },
     {
      "set": {
       "Custom_Disease": [
        "COVID-19"
       ]
      }
     },
     {
      "set": {
       "BioAssay": [
        "molecular docking"
       ]
      }
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "list",
         "name": "complex"
        }
       },
       [
        [
         [
          {
           "function": {
            "type": "abundance",
            "name": "protein"
           }
          },
          [
           {
            "namespace": "CHEBI",
            "name": "porphyrins"
           }
          ]
         ],
         [
          {
           "function": {
            "type": "abundance",
            "name": "protein"
           }
          },
          [
           {
            "namespace": "COVID",
            "name": "S"
           }
          ]
         ]
        ]
       ]
      ]
     },
     {
      "relation": "positive_correlation"
     },
     {
      "object": [
       {
        "function": {
         "type": "process",
         "name": "pathology"
        }
       },
       [
        {
         "namespace": "DO",
         "name": "COVID-19"
        }
       ]
      ]
     }
    ]
   },
   {
    "sets": [
     {
      "evidence": "The docking result is shown in Figure 7.A-1, where is the molecular model of the orf1ab protein binding to the porphyrin. The binding part of the orf1ab protein acts like a clip. It was this clip that grasps the porphyrin without the iron ion."
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "list",
         "name": "complex"
        }
       },
       [
        [
         [
          {
           "function": {
            "type": "abundance",
            "name": "abundance"
           }
          },
          [
           {
            "namespace": "CHEBI",
            "name": "porphyrins"
           }
          ]
         ],
         [
          {
           "function": {
            "type": "abundance",
            "name": "protein"
           }
          },
          [
           {
            "namespace": "COVID",
            "name": "ORF1ab"
           }
          ]
         ]
        ]
       ]
      ]
     },
     {
      "relation": "positive_correlation"
     },
     {
      "object": [
       {
        "function": {
         "type": "process",
         "name": "pathology"
        }
       },
       [
        {
         "namespace": "DO",
         "name": "COVID-19"
        }
       ]
      ]
     }
    ]
   },
   {
    "sets": [
     {
      "evidence": "The docking result (Figure 7.B-1) represents the molecular model of ORF8 protein binding to the porphyrin."
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "list",
         "name": "complex"
        }
       },
       [
        [
         [
          {
           "function": {
            "type": "abundance",
            "name": "abundance"
           }
          },
          [
           {
            "namespace": "CHEBI",
            "name": "porphyrins"
           }
          ]
         ],
         [
          {
           "function": {
            "type": "abundance",
            "name": "protein"
           }
          },
          [
           {
            "namespace": "COVID",
            "name": "ORF8"
           }
          ]
         ]
        ]
       ]
      ]
     },
     {
      "relation": "positive_correlation"
     },
     {
      "object": [
       {
        "function": {
         "type": "process",
         "name": "pathology"
        }
       },
       [
        {
         "namespace": "DO",
         "name": "COVID-19"
        }
       ]
      ]
     }
    ]
   },
   {
    "sets": [
     {
      "evidence": "The ORF7a protein and the porphyrin had the highest binding energy (37,123.79 kcal/mol)."
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "list",
         "name": "complex"
        }
       },
       [
        [
         [
          {
           "function": {
            "type": "abundance",
            "name": "abundance"
           }
          },
          [
           {
            "namespace": "CHEBI",
            "name": "porphyrins"
           }
          ]
         ],
         [
          {
           "function": {
            "type": "abundance",
            "name": "protein"
           }
          },
          [
           {
            "namespace": "COVID",
            "name": "ORF7a"
           }
          ]
         ]
        ]
       ]
      ]
     },
     {
      "relation": "positive_correlation"
     },
     {
      "object": [
       {
        "function": {
         "type": "process",
         "name": "pathology"
        }
       },
       [
        {
         "namespace": "DO",
         "name": "COVID-19"
        }
       ]
      ]
     }
    ]
   },
   {
    "sets": [
     {
      "evidence": "According to the results of Figure 4.A-2, further analysis showed that some amino acids (for example VALA:952, ALA A:956, ALA B:956, ASN A:955 etc.) of the E2 glycoprotein could bind to not only chloroquine phosphate, but also the porphyrins. In other words, the chloroquine has a one-third chance of inhibiting viral E2 glycoprotein and reducing patient symptoms."
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "list",
         "name": "complex"
        }
       },
       [
        [
         [
          {
           "function": {
            "type": "abundance",
            "name": "abundance"
           }
          },
          [
           {
            "namespace": "PUBCHEM",
            "name": "64927"
           }
          ]
         ],
         [
          {
           "function": {
            "type": "abundance",
            "name": "protein"
           }
          },
          [
           {
            "namespace": "COVID",
            "name": "S"
           }
          ]
         ]
        ]
       ]
      ]
     },
     {
      "relation": "negative_correlation"
     },
     {
      "object": [
       {
        "function": {
         "type": "process",
         "name": "pathology"
        }
       },
       [
        {
         "namespace": "DO",
         "name": "COVID-19"
        }
       ]
      ]
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "list",
         "name": "complex"
        }
       },
       [
        [
         [
          {
           "function": {
            "type": "abundance",
            "name": "abundance"
           }
          },
          [
           {
            "namespace": "PUBCHEM",
            "name": "64927"
           }
          ]
         ],
         [
          {
           "function": {
            "type": "abundance",
            "name": "protein"
           }
          },
          [
           {
            "namespace": "COVID",
            "name": "S"
           }
          ]
         ]
        ]
       ]
      ]
     },
     {
      "relation": "decreases"
     },
     {
      "object": [
       {
        "function": {
         "type": "process",
         "name": "activity"
        }
       },
       [
        [
         {
          "function": {
           "type": "abundance",
           "name": "protein"
          }
         },
         [
          {
           "namespace": "COVID",
           "name": "S"
          }
         ]
        ]
       ]
      ]
     }
    ]
   },
   {
    "sets": [
     {
      "evidence": "The binding energy of chloroquine to the nucleocapsid phosphoprotein is 198,815.22 kcal/mol, which is only equivalent to the 1.4% of the binding energy of the nucleocapsid phosphoprotein and the porphyrin."
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "list",
         "name": "complex"
        }
       },
       [
        [
         [
          {
           "function": {
            "type": "abundance",
            "name": "abundance"
           }
          },
          [
           {
            "namespace": "PUBCHEM",
            "name": "64927"
           }
          ]
         ],
         [
          {
           "function": {
            "type": "abundance",
            "name": "protein"
           }
          },
          [
           {
            "namespace": "COVID",
            "name": "N"
           }
          ]
         ]
        ]
       ]
      ]
     },
     {
      "relation": "decreases"
     },
     {
      "object": [
       {
        "function": {
         "type": "list",
         "name": "complex"
        }
       },
       [
        [
         [
          {
           "function": {
            "type": "abundance",
            "name": "abundance"
           }
          },
          [
           {
            "namespace": "CHEBI",
            "name": "porphyrins"
           }
          ]
         ],
         [
          {
           "function": {
            "type": "abundance",
            "name": "protein"
           }
          },
          [
           {
            "namespace": "COVID",
            "name": "N"
           }
          ]
         ]
        ]
       ]
      ]
     }
    ]
   },
   {
    "sets": [
     {
      "evidence": "The binding energy of chloroquine and the orf1ab protein is 4,584,302.64 kcal/mol, which equals 8-fold of the binding energy between the orf1ab and the porphyrin."
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "list",
         "name": "complex"
        }
       },
       [
        [
         [
          {
           "function": {
            "type": "abundance",
            "name": "abundance"
           }
          },
          [
           {
            "namespace": "PUBCHEM",
            "name": "64927"
           }
          ]
         ],
         [
          {
           "function": {
            "type": "abundance",
            "name": "protein"
           }
          },
          [
           {
            "namespace": "COVID",
            "name": "ORF1ab"
           }
          ]
         ]
        ]
       ]
      ]
     },
     {
      "relation": "decreases"
     },
     {
      "object": [
       {
        "function": {
         "type": "list",
         "name": "complex"
        }
       },
       [
        [
         [
          {
           "function": {
            "type": "abundance",
            "name": "abundance"
           }
          },
          [
           {
            "namespace": "CHEBI",
            "name": "porphyrins"
           }
          ]
         ],
         [
          {
           "function": {
            "type": "abundance",
            "name": "protein"
           }
          },
          [
           {
            "namespace": "COVID",
            "name": "ORF1ab"
           }
          ]
         ]
        ]
       ]
      ]
     }
    ]
   },
   {
    "sets": [
     {
      "evidence": "The binding energy of chloroquine to the ORF8 protein is 4,707,657.39 kcal/mol, which is only equivalent to 37% of the binding energy of the ORF8 protein to the porphyrin."
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "list",
         "name": "complex"
        }
       },
       [
        [
         [
          {
           "function": {
            "type": "abundance",
            "name": "abundance"
           }
          },
          [
           {
            "namespace": "PUBCHEM",
            "name": "64927"
           }
          ]
         ],
         [
          {
           "function": {
            "type": "abundance",
            "name": "protein"
           }
          },
          [
           {
            "namespace": "COVID",
            "name": "ORF8"
           }
          ]
         ]
        ]
       ]
      ]
     },
     {
      "relation": "decreases"
     },
     {
      "object": [
       {
        "function": {
         "type": "list",
         "name": "complex"
        }
       },
       [
        [
         [
          {
           "function": {
            "type": "abundance",
            "name": "abundance"
           }
          },
          [
           {
            "namespace": "CHEBI",
            "name": "porphyrins"
           }
          ]
         ],
         [
          {
           "function": {
            "type": "abundance",
            "name": "protein"
           }
          },
          [
           {
            "namespace": "COVID",
            "name": "ORF8"
           }
          ]
         ]
        ]
       ]
      ]
     }
    ]
   },
   {
    "sets": [
     {
      "evidence": "The binding energy of chloroquine to the ORF7a protein is 497,154.45 kcal / mol, which equals 13-fold of the binding energy of the ORF7a protein to the porphyrin."
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "list",
         "name": "complex"
        }
       },
       [
        [
         [
          {
           "function": {
            "type": "abundance",
            "name": "abundance"
           }
          },
          [
           {
            "namespace": "PUBCHEM",
            "name": "64927"
           }
          ]
         ],
         [
          {
           "function": {
            "type": "abundance",
            "name": "protein"
           }
          },
          [
           {
            "namespace": "COVID",
            "name": "ORF7a"
           }
          ]
         ]
        ]
       ]
      ]
     },
     {
      "relation": "decreases"
     },
     {
      "object": [
       {
        "function": {
         "type": "list",
         "name": "complex"
        }
       },
       [
        [
         [
          {
           "function": {
            "type": "abundance",
            "name": "abundance"
           }
          },
          [
           {
            "namespace": "CHEBI",
            "name": "porphyrins"
           }
          ]
         ],
         [
          {
           "function": {
            "type": "abundance",
            "name": "protein"
           }
          },
          [
           {
            "namespace": "COVID",
            "name": "ORF7a"
           }
          ]
         ]
        ]
       ]
      ]
     }
    ]
   },
   {
    "sets": [
     {
      "evidence": "These results marked the chloroquine could inhibit E2 and ORF8 bind to the porphyrin to form a complex respectively to a certain extent. Meanwhile, chloroquine could prevent orf1ab, ORF3a and ORF10 to attack the heme to form the porphyrin."
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "list",
         "name": "complex"
        }
       },
       [
        [
         [
          {
           "function": {
            "type": "abundance",
            "name": "abundance"
           }
          },
          [
           {
            "namespace": "PUBCHEM",
            "name": "64927"
           }
          ]
         ],
         [
          {
           "function": {
            "type": "abundance",
            "name": "protein"
           }
          },
          [
           {
            "namespace": "COVID",
            "name": "S"
           }
          ]
         ]
        ]
       ]
      ]
     },
     {
      "relation": "decreases"
     },
     {
      "object": [
       {
        "function": {
         "type": "list",
         "name": "complex"
        }
       },
       [
        [
         [
          {
           "function": {
            "type": "abundance",
            "name": "abundance"
           }
          },
          [
           {
            "namespace": "CHEBI",
            "name": "porphyrins"
           }
          ]
         ],
         [
          {
           "function": {
            "type": "abundance",
            "name": "protein"
           }
          },
          [
           {
            "namespace": "COVID",
            "name": "S"
           }
          ]
         ]
        ]
       ]
      ]
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "list",
         "name": "complex"
        }
       },
       [
        [
         [
          {
           "function": {
            "type": "abundance",
            "name": "abundance"
           }
          },
          [
           {
            "namespace": "PUBCHEM",
            "name": "64927"
           }
          ]
         ],
         [
          {
           "function": {
            "type": "abundance",
            "name": "protein"
           }
          },
          [
           {
            "namespace": "COVID",
            "name": "ORF8"
           }
          ]
         ]
        ]
       ]
      ]
     },
     {
      "relation": "decreases"
     },
     {
      "object": [
       {
        "function": {
         "type": "list",
         "name": "complex"
        }
       },
       [
        [
         [
          {
           "function": {
            "type": "abundance",
            "name": "abundance"
           }
          },
          [
           {
            "namespace": "CHEBI",
            "name": "porphyrins"
           }
          ]
         ],
         [
          {
           "function": {
            "type": "abundance",
            "name": "protein"
           }
          },
          [
           {
            "namespace": "COVID",
            "name": "ORF8"
           }
          ]
         ]
        ]
       ]
      ]
     }
    ]
   },
   {
    "sets": [
     {
      "evidence": "Favipiravir is the latest anti-novel coronavirus drug with specific therapeutic effects."
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "abundance",
         "name": "abundance"
        }
       },
       [
        {
         "namespace": "CHEBI",
         "name": "favipiravir"
        }
       ]
      ]
     },
     {
      "relation": "decreases"
     },
     {
      "object": [
       {
        "function": {
         "type": "process",
         "name": "pathology"
        }
       },
       [
        {
         "namespace": "DO",
         "name": "COVID-19"
        }
       ]
      ]
     }
    ]
   },
   {
    "sets": [
     {
      "evidence": "It is useful to note that the binding energy of Envelope protein and Favipiravir is more than 2700 times the binding energy of porphyrin."
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "list",
         "name": "complex"
        }
       },
       [
        [
         [
          {
           "function": {
            "type": "abundance",
            "name": "abundance"
           }
          },
          [
           {
            "namespace": "CHEBI",
            "name": "favipiravir"
           }
          ]
         ],
         [
          {
           "function": {
            "type": "abundance",
            "name": "protein"
           }
          },
          [
           {
            "namespace": "COVID",
            "name": "E"
           }
          ]
         ]
        ]
       ]
      ]
     },
     {
      "relation": "decreases"
     },
     {
      "object": [
       {
        "function": {
         "type": "list",
         "name": "complex"
        }
       },
       [
        [
         [
          {
           "function": {
            "type": "abundance",
            "name": "abundance"
           }
          },
          [
           {
            "namespace": "CHEBI",
            "name": "porphyrins"
           }
          ]
         ],
         [
          {
           "function": {
            "type": "abundance",
            "name": "protein"
           }
          },
          [
           {
            "namespace": "COVID",
            "name": "E"
           }
          ]
         ]
        ]
       ]
      ]
     }
    ]
   },
   {
    "sets": [
     {
      "evidence": "The binding energy of ORF7a to Favisiravir is 450 times higher than that of porphyrin, indicating that it can effectively avoid the non-structural protein of the virus capturing porphyrin."
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "list",
         "name": "complex"
        }
       },
       [
        [
         [
          {
           "function": {
            "type": "abundance",
            "name": "abundance"
           }
          },
          [
           {
            "namespace": "CHEBI",
            "name": "favipiravir"
           }
          ]
         ],
         [
          {
           "function": {
            "type": "abundance",
            "name": "protein"
           }
          },
          [
           {
            "namespace": "COVID",
            "name": "ORF7a"
           }
          ]
         ]
        ]
       ]
      ]
     },
     {
      "relation": "decreases"
     },
     {
      "object": [
       {
        "function": {
         "type": "list",
         "name": "complex"
        }
       },
       [
        [
         [
          {
           "function": {
            "type": "abundance",
            "name": "abundance"
           }
          },
          [
           {
            "namespace": "CHEBI",
            "name": "porphyrins"
           }
          ]
         ],
         [
          {
           "function": {
            "type": "abundance",
            "name": "protein"
           }
          },
          [
           {
            "namespace": "COVID",
            "name": "ORF7a"
           }
          ]
         ]
        ]
       ]
      ]
     }
    ]
   },
   {
    "sets": [
     {
      "evidence": "The binding energy of orf1ab and Favisiravir is 1.8 times higher than that of porphyrin, which shows that Faifiravir can prevent virus unstructured protein from attacking heme on hemoglobin."
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "list",
         "name": "complex"
        }
       },
       [
        [
         [
          {
           "function": {
            "type": "abundance",
            "name": "abundance"
           }
          },
          [
           {
            "namespace": "CHEBI",
            "name": "favipiravir"
           }
          ]
         ],
         [
          {
           "function": {
            "type": "abundance",
            "name": "protein"
           }
          },
          [
           {
            "namespace": "COVID",
            "name": "ORF1ab"
           }
          ]
         ]
        ]
       ]
      ]
     },
     {
      "relation": "decreases"
     },
     {
      "object": [
       {
        "function": {
         "type": "list",
         "name": "complex"
        }
       },
       [
        [
         [
          {
           "function": {
            "type": "abundance",
            "name": "abundance"
           }
          },
          [
           {
            "namespace": "CHEBI",
            "name": "porphyrins"
           }
          ]
         ],
         [
          {
           "function": {
            "type": "abundance",
            "name": "protein"
           }
          },
          [
           {
            "namespace": "COVID",
            "name": "ORF1ab"
           }
          ]
         ]
        ]
       ]
      ]
     }
    ]
   },
   {
    "sets": [
     {
      "unset": [
       "BioAssay"
      ]
     },
     {
      "unset": [
       "Custom_Disease"
      ]
     },
     {
      "unset": [
       "Section"
      ]
     },
     {
      "unset": [
       "PublicationStatus"
      ]
     },
     {
      "unset": [
       "PublicationType"
      ]
     },
     {
      "unset": [
       "Citation"
      ]
     }
    ]
   }
  ]
 }
]